Thyroid hydrolysis of cyclic AMP as influenced by thyroid gland activity

1971 ◽  
Vol 230 (2) ◽  
pp. 286-295 ◽  
Author(s):  
C.H. Bastomsky ◽  
M. Zakarija ◽  
J.M. McKenzie
2019 ◽  
Vol 47 (6) ◽  
pp. 1733-1747 ◽  
Author(s):  
Christina Klausen ◽  
Fabian Kaiser ◽  
Birthe Stüven ◽  
Jan N. Hansen ◽  
Dagmar Wachten

The second messenger 3′,5′-cyclic nucleoside adenosine monophosphate (cAMP) plays a key role in signal transduction across prokaryotes and eukaryotes. Cyclic AMP signaling is compartmentalized into microdomains to fulfil specific functions. To define the function of cAMP within these microdomains, signaling needs to be analyzed with spatio-temporal precision. To this end, optogenetic approaches and genetically encoded fluorescent biosensors are particularly well suited. Synthesis and hydrolysis of cAMP can be directly manipulated by photoactivated adenylyl cyclases (PACs) and light-regulated phosphodiesterases (PDEs), respectively. In addition, many biosensors have been designed to spatially and temporarily resolve cAMP dynamics in the cell. This review provides an overview about optogenetic tools and biosensors to shed light on the subcellular organization of cAMP signaling.


1993 ◽  
Vol 10 (6) ◽  
pp. 991-996 ◽  
Author(s):  
Ari Sitaramayya ◽  
Lorraine Lombardi ◽  
Alexander Margulis

AbstractDopamine is a major neurotransmitter and neuromodulator in vertebrate retina. Although its pharmacological and physiological actions are well understood, the biochemical mechanisms of its signal transduction are less clear. Acting via D1 receptors, dopamine was shown to increase cyclic AMP levels in intact retina and to activate adenylate cyclase in retinal homogenates. The action via activation of D2 receptors is controversial: it was reported to decrease cyclic AMP levels in intact retina but inhibition of cyclase could not be demonstrated in retinal homogenates; also it was reported to activate rod outer segment cyclic GMP phosphodiesterase in vitro but did not decrease cyclic GMP levels in aspartate-treated retinas. We made an attempt to fractionate bovine retinal membranes and to investigate the effects of dopamine, via Dl and D2 receptors, on the synthesis and hydrolysis of cyclic AMP and cyclic GMP. Activation of cyclic AMP synthesis was noted in all fractions, but no effects were evident on cyclic nucleotide hydrolysis or cyclic GMP synthesis in any fraction. Also, D2 agonist did not inhibit cyclic AMP synthesis. These observations suggest that D2 receptors may not be directly coupled to cyclic nucleotide metabolizing enzymes in bovine retina.


1968 ◽  
Vol 41 (1) ◽  
pp. 85-89 ◽  
Author(s):  
K. BROWN-GRANT

SUMMARY Serial measurements of peripheral blood 131I content beginning 96–120 hr. after the injection of radioactive iodide in rabbits were made to study possible short-term changes in thyroid gland activity after mating. No changes in the disappearance curve of blood radioactivity were detected after matings that induced ovulation or after the injection of human chorionic gonadotrophin. A dose of 12·5 m-u. thyrotrophin intravenously produced gross changes in the blood 131I levels, and mating was shown not to modify the response to this dose of thyrotrophin. It is concluded that, when ovulation is induced by mating in this species, no change in thyrotrophin secretion occurs; this finding is in contrast to results in species that ovulate 'spontaneously'.


1987 ◽  
Vol 7 (10) ◽  
pp. 751-755 ◽  
Author(s):  
Abdulrahim Abu-Jayyab ◽  
Ezz-Eddin S. M. El-Denshary ◽  
Abdulrahman M. Ageel ◽  
Mohamed Rafik Dakkak

Short-term and long-term effects of bromocriptine mesylate (10 mg/kg i.p.) on cyclic AMP contents of the liver and some endocrine glands have been investigated in the presence and absence of sulpiride (10 mg/kg i.p.). Results revealed that bromocriptine caused significant elevations in the cyclic AMP contents of the liver and reduction in its adrenocortical content. Bromocriptine effect on the adrenal cortex was antagonized by sulpiride, whereas its effect on the liver was not changed. Bromocriptine did not change the, cyclic AMP content in the thyroid gland or the ovary.


1962 ◽  
Vol 110 (1) ◽  
pp. 128-131 ◽  
Author(s):  
B. E. Eleftheriou ◽  
M. X. Zarrow

1974 ◽  
Vol 18 (6) ◽  
pp. 509-515 ◽  
Author(s):  
G. Chader ◽  
R. Fletcher ◽  
M. Johnson ◽  
R. Bensinger

Sign in / Sign up

Export Citation Format

Share Document